Ilya Izmailov

Mr. Ilya Izmailov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
Ksenia Sergeevna PokidovaKsenia Sergeevna Pokidova
Ksenia Sergeevna Pokidova
Egor KuzminEgor Kuzmin
Egor Kuzmin
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
IIIlya Izmailov
Ilya Izmailov
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, often linked to mutations in the FUS gene, leading to toxic protein aggregates. This study investigates the role of HSP70, a molecular chaperone, in mitigating neurodegeneration in FUS-ALS mouse models. Using quantitative immunofluorescence microscopy, we mapped cellular changes in the primary motor cortex of double transgenic FUS/HSP70 mice and compared them to single FUS-transgenic controls. Our results reveal that double transgenic mice exhibit significantly reduced neuronal damage and increased levels of mature neuronal (NeuN) and microglial (Iba1) markers, indicating a protective effect of HSP70. Intracellular HSP70 expression proved more effective than extracellular release, suggesting that targeted HSP70 delivery to neurons may offer a promising therapeutic avenue for ALS. This study underscores the potential of quantitative immunofluorescence for mapping neuroprotective pathways and highlights HSP70’s impact on mitigating FUS-related pathology in ALS.